putation was made.
TcPO2 and SPP tests require more expensive equipment and greater expertise for application than other
bedside testing, which may be a barrier for centres in
low or middle income countries. Although healthcare expenditures may increase with each of these measurements, incorrect assessment of the severity of PAD can
result in inadequate treatment and poorer outcomes
with ultimately an increase in costs. Importantly, all the
aforementioned bedside tests have varying capacity to
predict likelihood of healing and of